Listed

Stoke Therapeutics, Inc.

STOKNasdaqCIK 1623526HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$9.3m, Q2 FY2026
Operating income−$65.4m, Q2 FY2026
Net income−$61.6m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m3.3Revenue, Q3 FY2023, three months to 2023-09-30$3.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2024-11-05, accession 0000950170-24-121445.Report this figure2.8Revenue, Q4 FY2023, three months to 2023-12-31$2.8m. XBRL concept us-gaap:Revenues. 10-K filed 2025-03-18, accession 0000950170-25-041170. Derived: 12-month figure less the 9-month figure.Report this figure4.2Revenue, Q1 FY2024, three months to 2024-03-31$4.2m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-05-13, accession 0000950170-25-070296.Report this figure4.8Revenue, Q2 FY2024, three months to 2024-06-30$4.8m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-08-12, accession 0000950170-25-107332.Report this figure4.9Revenue, Q3 FY2024, three months to 2024-09-30$4.9m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-04, accession 0001193125-25-264720.Report this figure22.6Revenue, Q4 FY2024, three months to 2024-12-31$22.6m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-16, accession 0001193125-26-108362. Derived: 12-month figure less the 9-month figure.Report this figure159Revenue, Q1 FY2025, three months to 2025-03-31$158.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-07, accession 0001193125-26-211874.Report this figure13.8Revenue, Q2 FY2025, three months to 2025-06-30$13.8m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-03, accession 0001193125-26-330557.Report this figure10.6Revenue, Q3 FY2025, three months to 2025-09-30$10.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-04, accession 0001193125-25-264720.Report this figure1.4Revenue, Q4 FY2025, three months to 2025-12-31$1.4m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-16, accession 0001193125-26-108362. Derived: 12-month figure less the 9-month figure.Report this figure6.2Revenue, Q1 FY2026, three months to 2026-03-31$6.2m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-07, accession 0001193125-26-211874.Report this figure9.3Revenue, Q2 FY2026, three months to 2026-06-30$9.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-03, accession 0001193125-26-330557.Report this figure
Research and development$m20.3Research and development, Q3 FY2023, three months to 2023-09-30$20.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-05, accession 0000950170-24-121445.Report this figure21.8Research and development, Q4 FY2023, three months to 2023-12-31$21.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-18, accession 0000950170-25-041170. Derived: 12-month figure less the 9-month figure.Report this figure22.4Research and development, Q1 FY2024, three months to 2024-03-31$22.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-13, accession 0000950170-25-070296.Report this figure21.1Research and development, Q2 FY2024, three months to 2024-06-30$21.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-12, accession 0000950170-25-107332.Report this figure22.2Research and development, Q3 FY2024, three months to 2024-09-30$22.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-04, accession 0001193125-25-264720.Report this figure23.4Research and development, Q4 FY2024, three months to 2024-12-31$23.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-16, accession 0001193125-26-108362. Derived: 12-month figure less the 9-month figure.Report this figure32.7Research and development, Q1 FY2025, three months to 2025-03-31$32.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001193125-26-211874.Report this figure25.9Research and development, Q2 FY2025, three months to 2025-06-30$25.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-03, accession 0001193125-26-330557.Report this figure37.7Research and development, Q3 FY2025, three months to 2025-09-30$37.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-04, accession 0001193125-25-264720.Report this figure41.7Research and development, Q4 FY2025, three months to 2025-12-31$41.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-16, accession 0001193125-26-108362. Derived: 12-month figure less the 9-month figure.Report this figure39.7Research and development, Q1 FY2026, three months to 2026-03-31$39.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001193125-26-211874.Report this figure49.5Research and development, Q2 FY2026, three months to 2026-06-30$49.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-03, accession 0001193125-26-330557.Report this figure
Selling, general and administrative$mnot reportednot reportednot reportednot reported12.7Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$12.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-04, accession 0001193125-25-264720.Report this figure12.8Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$12.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-16, accession 0001193125-26-108362. Derived: 12-month figure less the 9-month figure.Report this figure14.7Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$14.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-07, accession 0001193125-26-211874.Report this figure15.3Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$15.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-03, accession 0001193125-26-330557.Report this figure16.0Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$16.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-04, accession 0001193125-25-264720.Report this figure21.1Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$21.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-16, accession 0001193125-26-108362. Derived: 12-month figure less the 9-month figure.Report this figure20.0Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$20.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-07, accession 0001193125-26-211874.Report this figure25.3Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$25.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-03, accession 0001193125-26-330557.Report this figure
Operating income$m(27.2)Operating income, Q3 FY2023, three months to 2023-09-30−$27.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-05, accession 0000950170-24-121445.Report this figure(29.6)Operating income, Q4 FY2023, three months to 2023-12-31−$29.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-18, accession 0000950170-25-041170. Derived: 12-month figure less the 9-month figure.Report this figure(28.4)Operating income, Q1 FY2024, three months to 2024-03-31−$28.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-13, accession 0000950170-25-070296.Report this figure(29.3)Operating income, Q2 FY2024, three months to 2024-06-30−$29.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-12, accession 0000950170-25-107332.Report this figure(30.0)Operating income, Q3 FY2024, three months to 2024-09-30−$30.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-04, accession 0001193125-25-264720.Report this figure(13.7)Operating income, Q4 FY2024, three months to 2024-12-31−$13.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-16, accession 0001193125-26-108362. Derived: 12-month figure less the 9-month figure.Report this figure111Operating income, Q1 FY2025, three months to 2025-03-31$111.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-211874.Report this figure(27.3)Operating income, Q2 FY2025, three months to 2025-06-30−$27.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-03, accession 0001193125-26-330557.Report this figure(43.1)Operating income, Q3 FY2025, three months to 2025-09-30−$43.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-04, accession 0001193125-25-264720.Report this figure(61.4)Operating income, Q4 FY2025, three months to 2025-12-31−$61.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-16, accession 0001193125-26-108362. Derived: 12-month figure less the 9-month figure.Report this figure(53.4)Operating income, Q1 FY2026, three months to 2026-03-31−$53.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-211874.Report this figure(65.4)Operating income, Q2 FY2026, three months to 2026-06-30−$65.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-03, accession 0001193125-26-330557.Report this figure
Interest expense$mnot reportednot reported0.0Interest expense, Q1 FY2024, three months to 2024-03-31$22.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-05-13, accession 0000950170-25-070296.Report this figure0.0Interest expense, Q2 FY2024, three months to 2024-06-30$5.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-08-12, accession 0000950170-25-107332.Report this figure0.0Interest expense, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-04, accession 0001193125-25-264720.Report this figure(0.0)Interest expense, Q4 FY2024, three months to 2024-12-31−$1.0k. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-03-16, accession 0001193125-26-108362. Derived: 12-month figure less the 9-month figure.Report this figure0.0Interest expense, Q1 FY2025, three months to 2025-03-31$1.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-07, accession 0001193125-26-211874.Report this figure0.0Interest expense, Q2 FY2025, three months to 2025-06-30$3.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-08-03, accession 0001193125-26-330557.Report this figure0.0Interest expense, Q3 FY2025, three months to 2025-09-30$3.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-04, accession 0001193125-25-264720.Report this figure0.0Interest expense, Q4 FY2025, three months to 2025-12-31$3.0k. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-03-16, accession 0001193125-26-108362. Derived: 12-month figure less the 9-month figure.Report this figure0.0Interest expense, Q1 FY2026, three months to 2026-03-31$23.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-07, accession 0001193125-26-211874.Report this figure0.0Interest expense, Q2 FY2026, three months to 2026-06-30$17.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-08-03, accession 0001193125-26-330557.Report this figure
Income tax$m0.0Income tax, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-05, accession 0000950170-24-121445.Report this figurenot reported0.0Income tax, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-13, accession 0000950170-25-070296.Report this figure0.0Income tax, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-12, accession 0000950170-25-107332.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-04, accession 0001193125-25-264720.Report this figurenot reported1.3Income tax, Q1 FY2025, three months to 2025-03-31$1.3m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-07, accession 0001193125-26-211874.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-03, accession 0001193125-26-330557.Report this figure(1.3)Income tax, Q3 FY2025, three months to 2025-09-30−$1.3m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-04, accession 0001193125-25-264720.Report this figure0.0Income tax, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-16, accession 0001193125-26-108362. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-07, accession 0001193125-26-211874.Report this figure0.0Income tax, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-03, accession 0001193125-26-330557.Report this figure
Net income$m(24.5)Net income, Q3 FY2023, three months to 2023-09-30−$24.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-05, accession 0000950170-24-121445.Report this figure(27.0)Net income, Q4 FY2023, three months to 2023-12-31−$27.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-18, accession 0000950170-25-041170. Derived: 12-month figure less the 9-month figure.Report this figure(26.4)Net income, Q1 FY2024, three months to 2024-03-31−$26.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001193125-25-264720.Report this figure(25.7)Net income, Q2 FY2024, three months to 2024-06-30−$25.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001193125-25-264720.Report this figure(26.4)Net income, Q3 FY2024, three months to 2024-09-30−$26.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001193125-25-264720.Report this figure(10.5)Net income, Q4 FY2024, three months to 2024-12-31−$10.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-16, accession 0001193125-26-108362. Derived: 12-month figure less the 9-month figure.Report this figure113Net income, Q1 FY2025, three months to 2025-03-31$112.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-03, accession 0001193125-26-330557.Report this figure(23.5)Net income, Q2 FY2025, three months to 2025-06-30−$23.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-03, accession 0001193125-26-330557.Report this figure(38.3)Net income, Q3 FY2025, three months to 2025-09-30−$38.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001193125-25-264720.Report this figure(57.9)Net income, Q4 FY2025, three months to 2025-12-31−$57.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-16, accession 0001193125-26-108362. Derived: 12-month figure less the 9-month figure.Report this figure(50.0)Net income, Q1 FY2026, three months to 2026-03-31−$50.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-03, accession 0001193125-26-330557.Report this figure(61.6)Net income, Q2 FY2026, three months to 2026-06-30−$61.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-03, accession 0001193125-26-330557.Report this figure
Diluted EPS$ per share(0.55)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.55 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-05, accession 0000950170-24-121445.Report this figurenot reported(0.57)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.57 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-13, accession 0000950170-25-070296.Report this figure(0.46)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.46 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-12, accession 0000950170-25-107332.Report this figure(0.47)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.47 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-04, accession 0001193125-25-264720.Report this figurenot reported1.90Diluted EPS, Q1 FY2025, three months to 2025-03-31$1.90 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001193125-26-211874.Report this figure(0.40)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.40 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-03, accession 0001193125-26-330557.Report this figure(0.65)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.65 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-04, accession 0001193125-25-264720.Report this figurenot reported(0.79)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.79 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001193125-26-211874.Report this figure(0.93)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.93 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-03, accession 0001193125-26-330557.Report this figure
Basic EPS$ per share(0.55)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.55 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-05, accession 0000950170-24-121445.Report this figurenot reported(0.57)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.57 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-13, accession 0000950170-25-070296.Report this figure(0.46)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.46 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-12, accession 0000950170-25-107332.Report this figure(0.47)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.47 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-04, accession 0001193125-25-264720.Report this figurenot reported1.95Basic EPS, Q1 FY2025, three months to 2025-03-31$1.95 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001193125-26-211874.Report this figure(0.40)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.40 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-03, accession 0001193125-26-330557.Report this figure(0.65)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.65 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-04, accession 0001193125-25-264720.Report this figurenot reported(0.79)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.79 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001193125-26-211874.Report this figure(0.93)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.93 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-03, accession 0001193125-26-330557.Report this figure

Balance sheet

Cash and equivalents$110.0m, Q2 FY2026
Shareholders' equity$345.5m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m190Cash and equivalents, Q3 FY2023, at 2023-09-30$190.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-05, accession 0000950170-24-121445.Report this figure191Cash and equivalents, FY2023, at 2023-12-31$191.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-18, accession 0000950170-25-041170.Report this figure179Cash and equivalents, Q1 FY2024, at 2024-03-31$178.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-13, accession 0000950170-25-070296.Report this figure193Cash and equivalents, Q2 FY2024, at 2024-06-30$193.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-12, accession 0000950170-25-107332.Report this figure150Cash and equivalents, Q3 FY2024, at 2024-09-30$150.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-04, accession 0001193125-25-264720.Report this figure128Cash and equivalents, FY2024, at 2024-12-31$128.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-16, accession 0001193125-26-108362.Report this figure275Cash and equivalents, Q1 FY2025, at 2025-03-31$274.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001193125-26-211874.Report this figure101Cash and equivalents, Q2 FY2025, at 2025-06-30$101.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-03, accession 0001193125-26-330557.Report this figure83.4Cash and equivalents, Q3 FY2025, at 2025-09-30$83.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-04, accession 0001193125-25-264720.Report this figure84.2Cash and equivalents, FY2025, at 2025-12-31$84.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-03, accession 0001193125-26-330557.Report this figure156Cash and equivalents, Q1 FY2026, at 2026-03-31$155.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001193125-26-211874.Report this figure110Cash and equivalents, Q2 FY2026, at 2026-06-30$110.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-03, accession 0001193125-26-330557.Report this figure
Current assets$m230Current assets, Q3 FY2023, at 2023-09-30$230.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-07, accession 0000950170-23-060224.Report this figure215Current assets, FY2023, at 2023-12-31$215.3m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-18, accession 0000950170-25-041170.Report this figure193Current assets, Q1 FY2024, at 2024-03-31$193.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-06, accession 0000950170-24-053535.Report this figure297Current assets, Q2 FY2024, at 2024-06-30$297.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-07, accession 0000950170-24-092738.Report this figure254Current assets, Q3 FY2024, at 2024-09-30$253.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-05, accession 0000950170-24-121445.Report this figure233Current assets, FY2024, at 2024-12-31$232.8m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-16, accession 0001193125-26-108362.Report this figure376Current assets, Q1 FY2025, at 2025-03-31$375.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-13, accession 0000950170-25-070296.Report this figure270Current assets, Q2 FY2025, at 2025-06-30$270.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-12, accession 0000950170-25-107332.Report this figure272Current assets, Q3 FY2025, at 2025-09-30$272.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-04, accession 0001193125-25-264720.Report this figure306Current assets, FY2025, at 2025-12-31$305.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-03, accession 0001193125-26-330557.Report this figure367Current assets, Q1 FY2026, at 2026-03-31$366.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-07, accession 0001193125-26-211874.Report this figure323Current assets, Q2 FY2026, at 2026-06-30$322.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-03, accession 0001193125-26-330557.Report this figure
Total assets$m240Total assets, Q3 FY2023, at 2023-09-30$239.9m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-07, accession 0000950170-23-060224.Report this figure228Total assets, FY2023, at 2023-12-31$228.3m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-18, accession 0000950170-25-041170.Report this figure205Total assets, Q1 FY2024, at 2024-03-31$205.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-06, accession 0000950170-24-053535.Report this figure308Total assets, Q2 FY2024, at 2024-06-30$307.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-07, accession 0000950170-24-092738.Report this figure293Total assets, Q3 FY2024, at 2024-09-30$293.3m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-05, accession 0000950170-24-121445.Report this figure272Total assets, FY2024, at 2024-12-31$271.6m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-16, accession 0001193125-26-108362.Report this figure407Total assets, Q1 FY2025, at 2025-03-31$406.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-13, accession 0000950170-25-070296.Report this figure385Total assets, Q2 FY2025, at 2025-06-30$384.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-12, accession 0000950170-25-107332.Report this figure360Total assets, Q3 FY2025, at 2025-09-30$360.3m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-04, accession 0001193125-25-264720.Report this figure418Total assets, FY2025, at 2025-12-31$418.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-03, accession 0001193125-26-330557.Report this figure443Total assets, Q1 FY2026, at 2026-03-31$443.3m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-07, accession 0001193125-26-211874.Report this figure394Total assets, Q2 FY2026, at 2026-06-30$394.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-03, accession 0001193125-26-330557.Report this figure
Current liabilities$m25.2Current liabilities, Q3 FY2023, at 2023-09-30$25.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-07, accession 0000950170-23-060224.Report this figure30.8Current liabilities, FY2023, at 2023-12-31$30.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-18, accession 0000950170-25-041170.Report this figure35.6Current liabilities, Q1 FY2024, at 2024-03-31$35.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-06, accession 0000950170-24-053535.Report this figure44.5Current liabilities, Q2 FY2024, at 2024-06-30$44.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-07, accession 0000950170-24-092738.Report this figure49.9Current liabilities, Q3 FY2024, at 2024-09-30$49.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-05, accession 0000950170-24-121445.Report this figure40.1Current liabilities, FY2024, at 2024-12-31$40.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-16, accession 0001193125-26-108362.Report this figure44.7Current liabilities, Q1 FY2025, at 2025-03-31$44.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-13, accession 0000950170-25-070296.Report this figure38.7Current liabilities, Q2 FY2025, at 2025-06-30$38.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-12, accession 0000950170-25-107332.Report this figure41.7Current liabilities, Q3 FY2025, at 2025-09-30$41.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-04, accession 0001193125-25-264720.Report this figure57.9Current liabilities, FY2025, at 2025-12-31$57.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-03, accession 0001193125-26-330557.Report this figure40.8Current liabilities, Q1 FY2026, at 2026-03-31$40.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-07, accession 0001193125-26-211874.Report this figure41.9Current liabilities, Q2 FY2026, at 2026-06-30$41.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-03, accession 0001193125-26-330557.Report this figure
Total liabilities$m66.9Total liabilities, Q3 FY2023, at 2023-09-30$66.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-07, accession 0000950170-23-060224.Report this figure68.8Total liabilities, FY2023, at 2023-12-31$68.8m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-18, accession 0000950170-25-041170.Report this figure64.8Total liabilities, Q1 FY2024, at 2024-03-31$64.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-06, accession 0000950170-24-053535.Report this figure65.0Total liabilities, Q2 FY2024, at 2024-06-30$65.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-07, accession 0000950170-24-092738.Report this figure61.2Total liabilities, Q3 FY2024, at 2024-09-30$61.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-05, accession 0000950170-24-121445.Report this figure42.5Total liabilities, FY2024, at 2024-12-31$42.5m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-16, accession 0001193125-26-108362.Report this figure56.8Total liabilities, Q1 FY2025, at 2025-03-31$56.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-13, accession 0000950170-25-070296.Report this figure49.6Total liabilities, Q2 FY2025, at 2025-06-30$49.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-12, accession 0000950170-25-107332.Report this figure52.2Total liabilities, Q3 FY2025, at 2025-09-30$52.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-04, accession 0001193125-25-264720.Report this figure66.0Total liabilities, FY2025, at 2025-12-31$66.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-03, accession 0001193125-26-330557.Report this figure48.4Total liabilities, Q1 FY2026, at 2026-03-31$48.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-07, accession 0001193125-26-211874.Report this figure48.4Total liabilities, Q2 FY2026, at 2026-06-30$48.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-03, accession 0001193125-26-330557.Report this figure
Shareholders' equity$m173Shareholders' equity, Q3 FY2023, at 2023-09-30$173.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-05, accession 0000950170-24-121445.Report this figure160Shareholders' equity, FY2023, at 2023-12-31$159.6m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-16, accession 0001193125-26-108362.Report this figure140Shareholders' equity, Q1 FY2024, at 2024-03-31$140.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001193125-25-264720.Report this figure243Shareholders' equity, Q2 FY2024, at 2024-06-30$242.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001193125-25-264720.Report this figure232Shareholders' equity, Q3 FY2024, at 2024-09-30$232.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001193125-25-264720.Report this figure229Shareholders' equity, FY2024, at 2024-12-31$229.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-03, accession 0001193125-26-330557.Report this figure350Shareholders' equity, Q1 FY2025, at 2025-03-31$350.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-03, accession 0001193125-26-330557.Report this figure335Shareholders' equity, Q2 FY2025, at 2025-06-30$334.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-03, accession 0001193125-26-330557.Report this figure308Shareholders' equity, Q3 FY2025, at 2025-09-30$308.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001193125-25-264720.Report this figure352Shareholders' equity, FY2025, at 2025-12-31$352.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-03, accession 0001193125-26-330557.Report this figure395Shareholders' equity, Q1 FY2026, at 2026-03-31$394.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-03, accession 0001193125-26-330557.Report this figure346Shareholders' equity, Q2 FY2026, at 2026-06-30$345.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-03, accession 0001193125-26-330557.Report this figure

Cash flow

Operating cash flow−$56.6m, Q2 FY2026
Capital expenditure$2.0m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(17.3)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$17.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-05, accession 0000950170-24-121445. Derived: 9-month figure less the 6-month figure.Report this figure(20.6)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$20.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-18, accession 0000950170-25-041170. Derived: 12-month figure less the 9-month figure.Report this figure(24.6)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$24.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-13, accession 0000950170-25-070296.Report this figure(17.5)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$17.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-12, accession 0000950170-25-107332. Derived: 6-month figure less the 3-month figure.Report this figure(21.6)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$21.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-04, accession 0001193125-25-264720. Derived: 9-month figure less the 6-month figure.Report this figure(23.2)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$23.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-16, accession 0001193125-26-108362. Derived: 12-month figure less the 9-month figure.Report this figure132Operating cash flow, Q1 FY2025, three months to 2025-03-31$131.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001193125-26-211874.Report this figure(25.4)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$25.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-03, accession 0001193125-26-330557. Derived: 6-month figure less the 3-month figure.Report this figure(30.4)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$30.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-04, accession 0001193125-25-264720. Derived: 9-month figure less the 6-month figure.Report this figure(30.5)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$30.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-16, accession 0001193125-26-108362. Derived: 12-month figure less the 9-month figure.Report this figure(60.6)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$60.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001193125-26-211874.Report this figure(56.6)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$56.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-03, accession 0001193125-26-330557. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.4Capital expenditure, Q3 FY2023, three months to 2023-09-30$383.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-05, accession 0000950170-24-121445. Derived: 9-month figure less the 6-month figure.Report this figure0.2Capital expenditure, Q4 FY2023, three months to 2023-12-31$229.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-18, accession 0000950170-25-041170. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2024, three months to 2024-03-31$12.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-13, accession 0000950170-25-070296.Report this figure0.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$46.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-12, accession 0000950170-25-107332. Derived: 6-month figure less the 3-month figure.Report this figure0.1Capital expenditure, Q3 FY2024, three months to 2024-09-30$103.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-04, accession 0001193125-25-264720. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$42.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-16, accession 0001193125-26-108362. Derived: 12-month figure less the 9-month figure.Report this figure0.2Capital expenditure, Q1 FY2025, three months to 2025-03-31$152.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001193125-26-211874.Report this figure0.2Capital expenditure, Q2 FY2025, three months to 2025-06-30$154.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-03, accession 0001193125-26-330557. Derived: 6-month figure less the 3-month figure.Report this figure0.1Capital expenditure, Q3 FY2025, three months to 2025-09-30$132.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-04, accession 0001193125-25-264720. Derived: 9-month figure less the 6-month figure.Report this figure0.2Capital expenditure, Q4 FY2025, three months to 2025-12-31$232.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-16, accession 0001193125-26-108362. Derived: 12-month figure less the 9-month figure.Report this figure0.4Capital expenditure, Q1 FY2026, three months to 2026-03-31$353.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001193125-26-211874.Report this figure2.0Capital expenditure, Q2 FY2026, three months to 2026-06-30$2.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-03, accession 0001193125-26-330557. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)66.02m, Q2 FY2026
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares39.4Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3039,420,310 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-07, accession 0000950170-23-060224.Report this figure42.5Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3142,536,474 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-06, accession 0000950170-24-053535.Report this figure44.2Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3044,188,464 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-07, accession 0000950170-24-092738.Report this figure44.3Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3044,266,017 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-05, accession 0000950170-24-121445.Report this figure46.2Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3146,246,889 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-13, accession 0000950170-25-070296.Report this figure55.8Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3055,765,948 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-12, accession 0000950170-25-107332.Report this figure56.3Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3056,341,074 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-04, accession 0001193125-25-264720.Report this figure59.4Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3159,398,600 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001193125-26-211874.Report this figure58.4Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3058,353,855 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-03, accession 0001193125-26-330557.Report this figure58.6Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3058,611,677 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-04, accession 0001193125-25-264720.Report this figure63.1Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3163,063,507 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001193125-26-211874.Report this figure66.0Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3066,017,895 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-03, accession 0001193125-26-330557.Report this figure

Shares outstanding: 64.53mShares outstanding, period not labelled, at 2026-07-3064,526,242 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-03, accession 0001193125-26-330557.Report this figure at Jul 30, 2026, from the cover of the 10-Q filed Aug 3, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. Listed shows no prices and gives no investment advice.